Search

Your search keyword '"Courta, Jacqueline"' showing total 7 results
Start Over Author "Courta, Jacqueline"
7 results on '"Courta, Jacqueline"'

1. Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

Author

Gauthier, Laurent, Virone-Oddos, Angela, Beninga, Jochen, Rossi, Benjamin, Nicolazzi, Céline, Amara, Céline, Blanchard-Alvarez, Audrey, Gourdin, Nicolas, Courta, Jacqueline, Basset, Alexandra, Agnel, Magali, Guillot, Franceline, Grondin, Gwendoline, Bonnevaux, Hélène, Bauchet, Anne-Laure, Morel, Ariane, Morel, Yannis, Chiron, Marielle, and Vivier, Eric

Published
2023
Full Text
View/download PDF

2. Abstract 2960: The novel trifunctional anti-BCMA NK cell engager SAR’514 has potent in-vitro, in-vivo and ex-vivo anti-myeloma effect through dual NK cell engagement

Author

Tang, Alexandre, primary, Gauthier, Laurent, additional, Beninga, Jochen, additional, Rossi, Benjamin, additional, Gourdin, Nicolas, additional, Blanchard-Alvarez, Audrey, additional, Amara, Céline, additional, Courta, Jacqueline, additional, Basset, Alexandra, additional, Bourges, Dorothée, additional, Desjonqueres, Alexandre, additional, Menoret, Emmanuelle, additional, Pellat-Deceunynck, Catherine, additional, Moreau, Philippe, additional, Morel, Yannis, additional, Chiron, Marielle, additional, Vivier, Eric, additional, and Virone-Oddos, Angela, additional

Published
2023
Full Text
View/download PDF

3. The Novel Trifunctional Anti-BCMA NK Cell Engager SAR'514 Has Potent in-Vitro and in-Vivo Anti-Myeloma Effect through Dual NK Cell Engagement

Author

Tang, Alexandre, primary, Gauthier, Laurent, additional, Beninga, Jochen, additional, Rossi, Benjamin, additional, Gourdin, Nicolas, additional, Blanchard-Alvarez, Audrey, additional, Amara, Céline, additional, Courta, Jacqueline, additional, Basset, Alexandra, additional, Bourges, Dorothee, additional, Desjonqueres, Alexandre, additional, Menoret, Emmanuelle, additional, Pellat-Deceunynck, Catherine, additional, Moreau, Philippe, additional, Morel, Yannis, additional, Chiron, Marielle, additional, Virone-Oddos, Angela, additional, and Vivier, Eric, additional

Published
2022
Full Text
View/download PDF

4. Abstract 2909: CD123-CODV-TCE bispecific T-cell engager for acute myeloid leukemia (AML): Activity on primary AML and safety in non-human primates

Author

Bonnevaux, Helene, primary, Courta, Jacqueline, additional, Passe-Coutrin, Wilfried, additional, Bauchet, Anne-Laure, additional, Roobrouck, Annelies, additional, Amara, Celine, additional, Beys, Eric, additional, Balzano, Marielle, additional, Moulard, Maxime, additional, Meloni, Marco, additional, Dullaers, Melissa, additional, Chiron, Marielle, additional, and Virone-Oddos, Angela, additional

Published
2022
Full Text
View/download PDF

5. 852 Trifunctional NKp46/CD16a-NK cell engager targeting CD123 overcomes acute myeloid leukemia resistance to ADCC

Author

Gauthier, Laurent, primary, Virone-Oddos, Angela, additional, Beninga, Jochen, additional, Rossi, Benjamin, additional, Nicolazzi, Céline, additional, Amara, Céline, additional, Blanchard-Alvarez, Audrey, additional, Gourdin, Nicolas, additional, Courta, Jacqueline, additional, Basset, Alexandra, additional, Guillot, Franceline, additional, Grondin, Gwendoline, additional, Bonnevaux, Hélène, additional, Bauchet, Anne-Laure, additional, Morel, Ariane, additional, Morel, Yannis, additional, Chiron, Marielle, additional, and Vivier, Eric, additional

Published
2021
Full Text
View/download PDF

6. Stability Assessment of Fresh or Cryopreserved Whole Blood and Bone Marrow Samples from AML and B-ALL Patients to Monitor CD123 Receptor and Immune Cells Subsets

Author

Courta, Jacqueline, Balzano, Marielle, Passe-Coutrin, Wilfried, Lagier, Margaux, Grivel, Karine, Boulay Moine, Daniele, Beroual, Drifa, Bauchet, Anne-Laure, Venton, Geoffroy, Costello, Regis, and Moulard, Maxime

Abstract

Introduction: Compounds targeting CD123 are currently under clinical development for the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). As part of clinical trials, CD123 expression and immune cell subsets need be monitored by quantitative flow cytometry (qFC) in bone marrow (BM) aspirates and whole blood (WB) samples before and on-treatment.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results